BCAB - BioAtla reports Q2 results

2023-08-01 17:07:19 ET

• BioAtla press release ( NASDAQ: BCAB ): Q2 Net loss for the second quarter ended June 30, 2023 was $35.8 million compared to a net loss of $28.9 million for the same quarter in 2022.

• Net cash used in operating activities for the months ended June 30, 2023 was $46.7 million compared to net cash used in operating activities of $42.1 million for the same period in 2022.

• The increase in net cash used in operating activities for the first six months of 2023 is primarily due to an increase in research and development expense related to our program development efforts as compared to the first six months of 2022.

For further details see: